Literature DB >> 1721335

FK 506 rescue therapy for resistant rejection episodes in liver transplant recipients.

A M D'Alessandro1, M Kalayoglu, J D Pirsch, C Corwith, S J Knechtle, A Reed, F O Belzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721335

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients.

Authors:  G V Mazariegos; A A Salzedas; A Jain; J Reyes
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

2.  FK-506 and cyclosporine A (CsA) immunomodulation of the human gut mucosal immune system.

Authors:  Y Elitsur; X Liu; J Dosescu; J A Moshier
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

3.  Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; H Wright; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; J McMichael; W Irish; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-05       Impact factor: 10.864

4.  Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial.

Authors:  D H Van Thiel; P Carroll; K Abu-Elmagd; H Rodriguez-Rilo; W Irish; J McMichael; T E Starzl
Journal:  Am J Gastroenterol       Date:  1995-03       Impact factor: 10.864
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.